198 filings
Page 5 of 10
6-K
yl7eep4xv3o09ww331t1
7 Feb 23
FSD Pharma Inc. 6-K
8:30am
6-K
t0y0vhp6 9u
30 Jan 23
FSD Pharma Inc. 6-K
8:30am
6-K
g1w55oqz
17 Jan 23
Company Seeking to Initiate Phase 1 Clinical Trial for its First-in-Class Multiple Sclerosis Drug Candidate
8:30am
6-K
ftur16u1 9rq7ekj4u
13 Jan 23
FSD Pharma Inc. 6-K
8:30am
6-K
nuixr h4u
9 Jan 23
FSD Pharma Inc Announces Three Key Additions to Scientific and Clinical Expert Committee
8:36am
6-K
c3zkwdhoxu2 z6
6 Jan 23
FSD Pharma Inc. 6-K
8:30am
6-K
nhz2d09k
28 Nov 22
FSD Pharma Inc. 6-K
9:08pm
6-K
v1yca0 vb57goh49n
14 Nov 22
Condensed consolidated interim financial statements
6:02am
6-K
h1u958 tug1nk
10 Nov 22
FSD Pharma Inc. 6-K
9:00am
6-K
nsbwzgcp a1
29 Sep 22
FSD Pharma Inc. 6-K
8:30am
6-K
zzf6hbd5t7i7 xv6jlsa
12 Sep 22
FSD Pharma Inc. 6-K
8:42am
6-K
otbiqna42a
6 Sep 22
FSD Pharma Inc. 6-K
8:33am
6-K
gbj19vh4z75nv9
12 Aug 22
Condensed consolidated interim financial statements
4:58pm
6-K
uoow58roic lcs34
13 Jul 22
FSD Pharma Inc. 6-K
8:30am
6-K
q9gc5lwmyaccpdajq
27 Jun 22
FSD Pharma Inc. 6-K
8:55am
6-K
3d36fetztnf
31 May 22
FSD Pharma Inc. 6-K
8:30am
6-K
rujnpd3ykfc fws
24 May 22
FSD Pharma Inc. 6-K
9:24am
6-K
k8rvl74s21 cem24
23 May 22
Annual General Meeting of the Shareholders
4:29pm
6-K
7rcxzrhvw
13 May 22
Condensed consolidated interim financial statements
5:10pm
6-K
6e9fczb494ykaa
10 May 22
FSD Pharma Inc. 6-K
1:11pm